Usefulness of Low-Dose Splenic Irradiation prior to Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Elderly Patients with Myelofibrosis

The Janus kinase (JAK) 1 and 2 inhibitor, ruxolitinib, was recently approved in Japan and has been effective in many patients with myelofibrosis (MF). Although the inhibitor decreases splenomegaly and relieves MF-related symptoms, allogeneic hematopoietic cell transplantation (HCT) remains as the on...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsubara, Etsuko, Yamanouchi, Jun, Kitazawa, Riko, Azuma, Taichi, Fujiwara, Hiroshi, Hato, Takaaki, Yasukawa, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093251/
https://www.ncbi.nlm.nih.gov/pubmed/27840748
http://dx.doi.org/10.1155/2016/8751329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093251/
https://www.ncbi.nlm.nih.gov/pubmed/27840748
http://dx.doi.org/10.1155/2016/8751329

Ejemplares similares